UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nitric oxide (NO): an emerging target for the treatment of glaucoma

Investigative ophthalmology & visual science, 2014-08, Vol.55 (8), p.5005-5015

2014

Volltextzugriff (PDF)

The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies

Journal of ocular pharmacology and therapeutics, 2018-03, Vol.34 (1-2), p.52-60

2018

Volltextzugriff (PDF)

Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure

Advances in therapy, 2016-04, Vol.33 (4), p.532-552

2016

Volltextzugriff (PDF)

epidermal growth factor (EGF) -dependent interaction between GIT1 and sorting nexin 6 promotes degradation of the EGF receptor

The FASEB journal, 2008-10, Vol.22 (10), p.3607-3616

2008

Volltextzugriff (PDF)

Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt

Journal of molecular and cellular cardiology, 2004-10, Vol.37 (4), p.881-887

2004

Volltextzugriff (PDF)

Regulation of Endothelin-1-Induced Trabecular Meshwork Cell Contractility by Latanoprostene Bunod

Investigative ophthalmology & visual science, 2015-06, Vol.56 (6), p.4108-4116

2015

Volltextzugriff (PDF)

Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial

Optometry and vision science, 2018-03, Vol.95 (3), p.264-271

2018

Volltextzugriff (PDF)

Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells

Molecular vision, 2011-02, Vol.17, p.533-542

2011

Volltextzugriff (PDF)

Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38

Journal of ocular pharmacology and therapeutics, 2019-06, Vol.35 (5), p.291-300

2019

Volltextzugriff (PDF)

Nonclinical safety evaluation of boric acid and a novel borate-buffered contact lens multi-purpose solution, Biotrue™ multi-purpose solution

Contact lens & anterior eye, 2010-12, Vol.33, p.S24-S32

2010

Volltextzugriff (PDF)

Comparison of the effect of multipurpose contact lens solutions on the viability of cultured corneal epithelial cells

Contact lens & anterior eye, 2009-08, Vol.32 (4), p.171-175

2009

Volltextzugriff (PDF)

Dose Uniformity of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38% Compared with Prednisolone Acetate Ophthalmic Suspension 1

Ophthalmology and therapy, 2022-02, Vol.11 (1), p.435-441

2022

Volltextzugriff (PDF)

Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies

Clinical ophthalmology (Auckland, N.Z.), 2019-08, Vol.13, p.1427-1438

2019

Volltextzugriff (PDF)

Evidence for a non-MDR1 component in digoxin secretion by human intestinal Caco-2 epithelial layers

European journal of pharmacology, 2003, Vol.458 (1), p.49-56

2003

Volltextzugriff (PDF)

Half-lives of plasma membrane Na+/H+ exchangers NHE1-3: plasma membrane NHE2 has a rapid rate of degradation

American Journal of Physiology: Cell Physiology, 2001-12, Vol.281 (6), p.C2039-C2048

2001

Volltextzugriff (PDF)

Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells

Molecular vision, 2013-07, Vol.19, p.1515-1525

2013

Volltextzugriff (PDF)

Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy

Drug design, development and therapy, 2014-01, Vol.8 (default), p.745-757

2014

Volltextzugriff (PDF)

Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells

Molecular vision, 2010-09, Vol.16, p.1791-1800

2010

Volltextzugriff (PDF)

Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells

Experimental eye research, 2014-10, Vol.127, p.290-298

2014

Volltextzugriff (PDF)

BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells

Molecular vision, 2009-12, Vol.15, p.2606-2616

2009

Volltextzugriff (PDF)

Gas6-Axl Pathway: The Role of Redox-Dependent Association of Axl With Nonmuscle Myosin IIB

Hypertension (Dallas, Tex. 1979), 2010-07, Vol.56 (1), p.105-111

2010

Volltextzugriff (PDF)

Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis

Journal of asthma and allergy, 2018-01, Vol.11, p.29-39

2018

Volltextzugriff (PDF)

Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells

Arteriosclerosis, thrombosis, and vascular biology, 2008-05, Vol.28 (5), p.886-891

2008

Volltextzugriff (PDF)

Reduced Myocilin Expression in Cultured Monkey Trabecular Meshwork Cells Induced by a Selective Glucocorticoid Receptor Agonist: Comparison with Steroids

Investigative ophthalmology & visual science, 2010-01, Vol.51 (1), p.437-446

2010

Volltextzugriff (PDF)

GIT1 mediates HDAC5 activation by angiotensin II in vascular smooth muscle cells

Arteriosclerosis, thrombosis, and vascular biology, 2008-05, Vol.28 (5), p.892-898

2008

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Nitric oxide (NO): an emerging target for the treatment of glaucoma

The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies

Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure

epidermal growth factor (EGF) -dependent interaction between GIT1 and sorting nexin 6 promotes degradation of the EGF receptor

Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt

Regulation of Endothelin-1-Induced Trabecular Meshwork Cell Contractility by Latanoprostene Bunod

Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial

Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells

Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38

Nonclinical safety evaluation of boric acid and a novel borate-buffered contact lens multi-purpose solution, Biotrue™ multi-purpose solution

Comparison of the effect of multipurpose contact lens solutions on the viability of cultured corneal epithelial cells

Dose Uniformity of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38% Compared with Prednisolone Acetate Ophthalmic Suspension 1

Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies

Evidence for a non-MDR1 component in digoxin secretion by human intestinal Caco-2 epithelial layers

Half-lives of plasma membrane Na+/H+ exchangers NHE1-3: plasma membrane NHE2 has a rapid rate of degradation

Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells

Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy

Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells

Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells

BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells

Gas6-Axl Pathway: The Role of Redox-Dependent Association of Axl With Nonmuscle Myosin IIB

Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis

Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells

Reduced Myocilin Expression in Cultured Monkey Trabecular Meshwork Cells Induced by a Selective Glucocorticoid Receptor Agonist: Comparison with Steroids

GIT1 mediates HDAC5 activation by angiotensin II in vascular smooth muscle cells

Suchergebnisse filtern